APA (7th ed.) Citation

Moutachi, D., Lemaitre, M., Delacroix, C., Agbulut, O., Furling, D., & Ferry, A. (2023). Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical & Experimental Pharmacology & Physiology, 50(9), 749. https://doi.org/10.1111/1440-1681.13804

Chicago Style (17th ed.) Citation

Moutachi, Dylan, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, and Arnaud Ferry. "Valproic Acid Reduces Muscle Susceptibility to Contraction‐induced Functional Loss but Increases Weakness in Two Murine Models of Duchenne Muscular Dystrophy." Clinical & Experimental Pharmacology & Physiology 50, no. 9 (2023): 749. https://doi.org/10.1111/1440-1681.13804.

MLA (9th ed.) Citation

Moutachi, Dylan, et al. "Valproic Acid Reduces Muscle Susceptibility to Contraction‐induced Functional Loss but Increases Weakness in Two Murine Models of Duchenne Muscular Dystrophy." Clinical & Experimental Pharmacology & Physiology, vol. 50, no. 9, 2023, p. 749, https://doi.org/10.1111/1440-1681.13804.